Gold-Catalyzed Intramolecular Alkyne Cycloisomerization Cascade:
8.0 Hz, 1H, 7-H), 7.81–7.83 (m, 1H, 4-H), 7.95 (br s, 1H,
NH); 13C NMR (125 MHz, C6D6): d=111.9, 117.9, 120.6,
121.4, 121.6, 122.0, 123.2, 125.0, 125.4, 125.8, 126.3, 128.9,
129.2 (2C), 129.8, 130.4 (2C), 133.3, 136.3, 137.8, 139.8,
142.5; HR-MS (FAB): m/z=293.1208, calcd. for C22H15N
[M+]: 293.1204.
Acknowledgements
This work was supported in part by Kaken Pharmaceutical
Co., Ltd., a Grant-in-Aid for Encouragement of Young Sci-
entists (A) from the Ministry of Education, Culture, Sports,
Science and Technology of Japan, Targeted Proteins Research
Program, and the Program for Promotion of Fundamental
Studies in Health Sciences of the National Institute of Bio-
medical Innovation (NIBIO). T.W. is grateful to Research
Fellowships of the Japan Society for the Promotion of Sci-
ence (JSPS) for Young Scientists.
References
Scheme 3. Cascade cyclizations of heterocyclic congeners.
[1] For recent reviews on cascade reactions, see; a) L. F.
Tietze, Chem. Rev. 1996, 96, 115–136; b) K. C. Nico-
laou, D. J. Edmonds, P. G. Bulger, Angew. Chem. 2006,
118, 7292–7344; Angew. Chem. Int. Ed. 2006, 45, 7134–
7186; c) S. F. Kirsch, Synthesis 2008, 3183–3204.
from the single substrates by simply changing the re-
action conditions.
[2] For recent reviews on gold catalysis: a) A. S. K.
Hashmi, Chem. Rev. 2007, 107, 3180–3211; b) D. J.
Gorin, F. D. Toste, Nature 2007, 446, 395–403; c) E. Ji-
In conclusion, we have developed a novel gold-cat-
alyzed intramolecular cascade cyclization for the syn-
thesis of aryl- and heteroaryl-annulated[a]carbazoles.
This reaction is applicable to various aryl-annulate-
d[a]carbazoles containing an alkyl or aryl substituent.
It provides potent methodology for the fields of drug
discovery and materials chemistry.
ˇ
mꢂnez-Nfflnez, A. M. Echavarren, Chem. Rev. 2008,
108, 3326–3350; d) N. T. Patil, Y. Yamamoto, Chem.
Rev. 2008, 108, 3395–3442.
[3] For reviews, see: a) G. H. Kirsch, Curr. Org. Chem.
2001, 5, 507–518; b) H.-J. Knçlker, K. R. Reddy,
Chem. Rev. 2002, 102, 4303–4427; c) F. Bellina, R.
Rossi, Tetrahedron 2006, 62, 7213–7256.
[4] a) E. Lescot, G. Muzard, J. Markovits, J. Belleney, B. P.
Roques, J.-B. Le Pecq, J. Med. Chem. 1986, 29, 1731–
1737; b) C. M. Cavazos, S. T. Keir, T. Yoshinari, D. D.
Bigner, H. S. Friedman, Cancer Chemother. Pharmacol.
2001, 48, 250–254.
[5] T. A. Choi, R. Czerwonka, W. Frçhner, M. P. Krahl,
K. R. Reddy, S. G. Franzblau, H.-J. Knçlker, Chem-
MedChem 2006, 1, 812–815.
Experimental Section
Representative Procedure for Synthesis of Aryl- and
Heteroaryl-annulated[a]carbazoles. Synthesis of 6-
Phenyl-11H-benzo[a]carbazole (2a) (Table 1,
Entry 13)
A mixture of Ph3PAuCl (2.9 mg, 5.9 mmol) and AgOTf
(1.5 mg, 5.9 mmol) in acetonitrile (0.59 mL) was stirred at
room temperature under argon. After 2-{[2-(phenylethynyl)-
phenyl]ethynyl}aniline (1a) (34 mg, 0.12 mmol) was added,
the mixture was stirred at 808C for 1.5 h. The reaction mix-
ture was deluted with EtOAc, washed with saturated aque-
ous NH4Cl and brine, dried over Na2SO4, filtered, and con-
centrated under vacuum. The residue was purified by
column chromatography (Chromatorexꢁ NH) with n-
hexane/EtOAc (3:1) to afford 2a as a yellow solid; yield:
29 mg (80% yield); mp 164–1658C; IR (neat): n=3429 cmÀ1
[6] J. P. Chen, H. Tanabe, X.-C. Li, T. Thoms, Y. Okamura,
K. Ueno, Synth. Met. 2003, 132, 173–176.
[7] J. You, W. Zhao, L. Liu, X. Zhao, Y. Suo, H. Wang, Y.
Li, C. Ding, Talanta 2007, 72, 914–925.
[8] a) H. Ohno, Y. Ohta, S. Oishi, N. Fujii, Angew. Chem.
2007, 119, 2345–2348; Angew. Chem. Int. Ed. 2007, 46,
2295–2298; b) T. Watanabe, S. Ueda, S. Inuki, S. Oishi,
N. Fujii, H. Ohno, Chem. Commun. 2007, 4516–4518;
c) H. Ohno, M. Iuchi, N. Fujii, T. Tanaka, Org. Lett.
2007, 9, 4813–4815; d) Y. Ohta, S. Oishi, N. Fujii, H.
Ohno, Chem. Commun. 2008, 835–837; e) H. Ohno, A.
Okano, S. Kosaka, K. Tsukamoto, M. Ohata, K. Ishi-
hara, H. Maeda, T. Tanaka, N. Fujii, Org. Lett. 2008,
10, 1171–1174; f) Y. Ohta, H. Chiba, S. Oishi, N. Fujii,
H. Ohno, Org. Lett. 2008, 10, 3535–3538; g) A. Okano,
1
(NH); H NMR (500 MHz, C6D6): d=7.04 (ddd, J=8.0, 6.9,
1.2 Hz, 1H, 8-H), 7.23 (d, J=8.0 Hz, 1H, 10-H), 7.24–7.33
(m, 4H, 9-H and Ph), 7.35–7.40 (m, 2H, 2-H and 3-H), 7.48
(s, 1H, 5-H), 7.63–7.67 (m, 3H, 1-H and Ph), 7.78 (d, J=
Adv. Synth. Catal. 2010, 352, 368 – 372
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
371